You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金域醫學(603882.SH):半年度淨利預減78.70%到84.17%
格隆匯 07-14 20:44

格隆匯7月14日丨金域醫學(603882.SH)公佈2023年半年度業績預減公吿,經財務部門初步測算,預計2023年半年度實現歸屬於上市公司股東的淨利潤為26,000萬元到35,000萬元,與上年同期相比,將下降129,296.90萬元到138,296.90萬元,同比下降78.70%到84.17%。

公司預計2023年半年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤為25,000萬元到34,000萬元,與上年同期相比,將下降126,473.85萬元到135,473.85萬元,扣除非經常性損益事項後同比下降78.81%到84.42%。

本期業績預減的主要原因:報吿期內,受檢驗需求減少影響,公司醫學診斷服務收入較去年下降明顯,報吿期內盈利水平較去年同期回落。在“高質量發展、創新驅動發展、集團一盤棋”的戰略思想指導下,公司確定2023年為提質增效年,通過精細化管理不斷提升運營效率。報吿期內,公司常規醫學診斷服務業務穩步恢復。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account